Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel

Affiliations

• ¹ Division of Hematology/Oncology, Department of Pediatrics, the Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
• ² Department of Pediatrics, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
• ³ Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.
• ⁴ Division of Hematology/Oncology, Children's Hospital and Research Center Oakland, Oakland, CA, USA.
• ⁵ Paediatric Haematology/Oncology, Hannover Medical School, Hannover, Germany.
• ⁶ Atlantic Health System, Goryeb Children's Hospital, Morristown, NJ, USA.
• ⁷ Department of Haematology and Oncology, Royal Hospital for Children, Glasgow, UK.
• ⁸ Haematology/Oncology, Hôpital Armand Trousseau, Paris, France.
• ⁹ Department of Oncology, Division of Leukemia/Lymphoma, St. Jude Children's Research Hospital, Memphis, TN, USA.
• ¹⁰ Department of Haematology/Oncology, Our Lady's Children's Hospital, Dublin, Ireland.
• ¹¹ Department of Paediatric Haematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
• ¹² University of Pavia, Pavia, Italy.
• ¹³ Paediatric Oncology, VU University Medical Centre, Amsterdam, The Netherlands.
• ¹⁴ Academy of Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands.